<DOC>
	<DOCNO>NCT00396084</DOCNO>
	<brief_summary>This study evaluate ability 4 antibiotic kill bacteria cause tuberculosis ( TB ) . The antibiotic study linezolid , gatifloxacin , levofloxacin , moxifloxacin . All approve Brazilian health authority treat infection cause germ TB . Seventy human immunodeficiency virus ( HIV ) -negative adult , age 18-65 year , newly diagnose pulmonary ( lung ) TB , participate study . Study volunteer give one 4 study drug comparison antibiotic , Isoniazid , use around world standard care treatment TB . Volunteers stay hospital 10 day give study antibiotic 7 day . Blood saliva sample take . Six week later , volunteer return final health check . All volunteer receive 6 month standard tuberculosis treatment .</brief_summary>
	<brief_title>Early Bactericidal Activity Linezolid , Gatifloxacin , Levofloxacin , Isoniazid ( INH ) Moxifloxacin HIV Negative Adults With Initial Episodes Sputum Smear-Positive Pulmonary Tuberculosis</brief_title>
	<detailed_description>Multi-drug resistant tuberculosis affect region world significant concern national tuberculosis ( TB ) control program . The development test new drug new class drug immunotherapeutic agent vital element global response challenge . The fluoroquinolones oxazolidinones represent two promising class drug show activity Mycobacterium tuberculosis ( MTB ) . This study randomize , open label , multiple dose phase I clinical trial evaluate early bactericidal activity ( EBA ) gatifloxacin , levofloxacin , moxifloxacin , linezolid compare isoniazid ( INH ) control arm patient newly-diagnosed sputum smear-positive pulmonary tuberculosis ( TB ) . Secondary study objective : compare result sputum MTB messenger ribonucleic acid ( mRNA ) clearance result standard EBA study [ change sputum viable count [ colony form unit ( CFU ) ] ; compare rate clearance sputum cytokine proteins result standard EBA assay CFU ; determine pharmacokinetics ( PK ) study drug patient smear-positive pulmonary TB ; demonstrate lack EBA activity due low serum drug concentration . Seventy human immunodeficiency virus ( HIV ) negative adult , age 18-65 year , newly diagnose pulmonary TB , enrol admitted Centro de Pesquisa ( Clinical Research Ward ) Hospital Universitario Cassiano Antonio de Moraes Universidade Federal Espírito Santo Vitória . The subject randomize receive gatifloxacin , levofloxacin , moxifloxacin , INH ( control ) , arm enrol , randomize receive either linezolid ( 600 mg daily ) linezolid ( 600 mg twice daily ) INH ( control ) . During inpatient stay , study drug give 7 day follow 2-day drug-free period baseline sputum bacillary count measure . The 7-day duration study drug phase allow measurement sputum bactericidal activity first 2 day study drug administration day 2 7 study drug administration gain additional information possible sterilizing activity drug . The extended nature EBA study allow assessment possibility study drug would miss short EBA study perform . Sputum specimens collect 2 day prior initiation study drug order establish baseline quantitative culture result specimen collect daily thereafter . Sputum specimens process evaluate change mycobacterial mRNA/proteins cytokine protein . PK study perform 5 day study drug administration ( Day 5 ) . Safety evaluation include clinical examination , complete blood count , serum total bilirubin , aspartate aminotransferase ( AST ) , creatinine , urinalysis follow monitor drug toxicity . Drug susceptibility test perform initial sputum isolate repeat completion 7 day study drug , isolate patient positive sputum culture day 42 study visit ass development acquire drug resistance . Isolates tested INH , rifampicin , pyrazinamide , ethambutol subject 's assigned study drug . Patients find resistant assign study drug baseline analyzable . After initial treatment , subject receive 6 month standard TB treatment outside hospital .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Adults , male female , age 18 65 year . Women childbearing potential ( surgically sterilize postmenopausal less 1 year ) must use agree use adequate method birth control [ condom ; intravaginal spermicide ( foams , jelly , sponge ) diaphragm ; cervical cap intrauterine device ] study drug treatment . Newly diagnose sputum smearpositive pulmonary tuberculosis confirm sputum acid fast bacillus ( AFB ) smear chest Xray finding consistent pulmonary tuberculosis . Willing able provide inform consent . Reasonably normal hemoglobin ( great equal 8 gm/dL ) , renal function ( serum creatinine le 2 mg/dL ) , hepatic function [ serum aspartate aminotransferase ( AST ) less 1.5 time upper limit normal test laboratory total bilirubin le 1.3 mg/dL ] , random blood glucose le 150 mg/dL . Human immunodeficiency virus ( HIV ) infection . Weight le 75 percent ideal body weight . Presence significant hemoptysis . Patients cough frank blood ( blood streak sputum ) eligible enrollment . Pregnant breastfeed woman practice birth control . Significant respiratory impairment ( respiratory rate great 35/minute ) . Clinical suspicion disseminate tuberculosis tuberculosis meningitis . Presence serious underlie medical illness , liver failure , renal failure , diabetes mellitus , chronic alcoholism , decompensated heart failure , hematologic malignancy patient receive myelosuppressive chemotherapy . Patients receive follow medication monoamine oxidase inhibitor ( phenelzine , tranylcypromine ) , adrenergic/serotonergic agonist pseudoephedrine phenylpropanolamine ( frequently find cold cough remedy ) , tricyclic antidepressant ( amitriptyline , nortriptyline , protriptyline , doxepin , amoxapine , etc ) , antipsychotic chlorpromazine buspirone , serotonin reuptake inhibitor ( fluoxetine , paroxetine , sertraline , etc . ) , buproprion , agent know prolong QTc interval [ erythromycin , clarithromycin , astemizole , type Ia ( quinidine , procainamide , disopyramide ) III ( amiodarone , sotalol ) antiarrhythmic , carbamazepine , insulin , sulfonylurea , meperidine . Presence QTc prolongation ( great 450 msec ) baseline electrocardiogram ( EKG ) . Allergy contraindication use study drug . Treatment antituberculosis medication antibiotic know activity M. tuberculosis precede 6 month . Inability provide inform consent . Total white blood cell count less 3000/mm^3 . Platelet count less 150,000/mm^3 . Patients suspected drug resistant tuberculosis ( e.g. , contact source patient drug resistant tuberculosis , patient relapse previous treatment tuberculosis ) . Patients likely , opinion local investigator , unable comply requirement study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>tuberculosis , linezolid , gatifloxacin , levofloxacin , isoniazid , moxifloxacin , Brazil</keyword>
</DOC>